Dr. Hartmann’s professional journey began with the attainment of his Doctor of Pharmacy degree at the University of Kansas. His early career unfolded within the pharmaceutical industry, specializing in neurology, mental health, and hematology/oncology therapeutic areas. Over more than two decades, Dr. Hartmann has carved a distinguished path in senior leadership roles, fueled by his unwavering passion for driving clinical trials, launching innovative products, and engaging with the nation’s Key Opinion Leaders in Hematology and Oncology. His commitment remains steadfast in seeking answers and pioneering new therapies to enhance the lives of patients and their families.
Driven by a curiosity about why patients respond differently to therapies, Dr. Hartmann embarked on a quest to unravel patterns of efficacy and side effects across various medications. This led him to pursue certifications in Pharmacogenomics and Nutrigenomics, aiming to identify genomic differences that hold the key to understanding patients’ health, well-being, and longevity.